Fidelis Partnership's IPO filing shows how much still rides on Pelagos
Why now
Thesis: Counterparty concentration is key IPO risk
Catalyst to watch: Pricing terms and investor demand
Main risk: Counterparty losses could hit results
Why it matters
IPO filing reveals reinsurance exposure tied to a single counterparty, a concentration risk for the listing.
Related assets & topics
CreditSources
- googlenews · news.google.com · 2026-09-28 06:51 UTC
- googlenews · news.google.com · 2026-09-28 06:51 UTC